Search Results

Pharmacologic Potential of Statins in Cancer Prevention: Colo-Rectal Cancer Risk in Dyslipidemic Patients from a Korean Nationwide Cohort.

• Authors : Kang, Ho Suk; Kim, Joo-Hee; Kim, Heejin

Subjects: COLORECTAL cancer; STATINS (Cardiovascular agents); CANCER preventionSOUTH Korea

• Source: Pharmaceuticals (14248247); Aug2025, Vol. 18 Issue 8, p1236, 18p

Record details

The Multifaceted Role and Regulation of Nlrp3 Inflammasome in Colitis-Associated Colo-Rectal Cancer: A Systematic Review.

• Authors : Zaharie, Roxana; Valean, Dan; Popa, Calin

Subjects: NLRP3 protein; INFLAMMATORY bowel diseases; INFLAMMASOMES

• Source: International Journal of Molecular Sciences; Feb2023, Vol. 24 Issue 4, p3472, 15p

Record details

Prophylactic para-aortic lymph node dissection in Colo-rectal cancer; pilot study.

• Authors : Abdalwahab, Abdalwahab R.; Abdelhamed, Mohamed A.; Gad, Mai

• Source: World Journal of Surgical Oncology; 9/19/2024, Vol. 22 Issue 1, p1-9, 9p

Record details

Optimizing peri-operative feeding to decrease post-operative stress response in patients with colo-rectal cancer.

• Authors : Awad, Joseph Rizk; Moursi, Adel Mahmoud; Abdelhamid, Mohamed I.

Subjects: CANCER patients; INFLAMMATORY mediators; STATISTICAL significance

• Source: Zagazig University Medical Journal; Mar2024, Vol. 30 Issue 2, p482-485, 4p

Record details

Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation.

• Authors : Udagawa, Shohei; Ooki, Akira; Shinozaki, Eiji

Subjects: MEDICAL quality control; GENETIC mutation; CANCER chemotherapy

• Source: Cancers; Mar2023, Vol. 15 Issue 5, p1473, 20p

Record details

Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center.

• Authors : Sharma, Vinod; Sharma, Atul; Raina, Vinod

• Source: BMC Cancer; 5/28/2021, Vol. 21 Issue 1, p1-12, 12p

Record details

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.

• Authors : Guilloteau, Adrien; Abrahamowicz, Michal; Boussari, Olayide

Subjects: CLINICAL trials; BEVACIZUMAB; SURVIVAL analysis (Biometry)

• Source: BMC Medical Research Methodology; 1/9/2021, Vol. 21 Issue 1, p1-10, 10p

Record details

Mesalazine inhibits the β-catenin signalling pathway acting through the upregulation of μ-protocadherin gene in colo-rectal cancer cells.

• Authors : PARENTI, S.; FERRARINI, F.; ZINI, R.

Subjects: CHEMOPREVENTION; COLON cancer; ANTI-inflammatory agents

• Source: Alimentary Pharmacology & Therapeutics; Jan2010, Vol. 31 Issue 1, p108-119, 12p, 2 Color Photographs, 1 Black and White Photograph, 3 Charts, 4 Graphs

Record details

Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance.

• Authors : Ammendola, Michele; Sacco, Rosario; Sammarco, Giuseppe

Subjects: RECTAL cancer patients; MAST cells; TRYPTASE

• Source: PLoS ONE; Jun2014, Vol. 9 Issue 6, p1-7, 7p

Record details

Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.

• Authors : Figer, A; Shtoyerman-Chen, R; Tamir, A

Subjects: COLON cancer; GENETIC mutation; PHENOTYPES

• Source: British Journal of Cancer; 11/1/2001, Vol. 85 Issue 9, p1368, 4p

Record details